<?xml version="1.0" encoding="UTF-8"?>
<fn-group>
 <fn fn-type="other">
  <p>
   <bold>Contributors:</bold> DPD conceived and designed the study. DPD is the principal investigator at the Division of Geriatric Psychiatry, Department of Psychiatry, New York State Psychiatric Institute and Columbia University Medical Center. HAW, WCK, QR, AG, YS, AM, TW, EA, JP, MK, KLB, GHP, DD, KMP, EDH provided editorial comments and contributed to the development and conduct of the study.
  </p>
 </fn>
 <fn fn-type="other">
  <p>
   <bold>Funding:</bold> The study is supported by grant R01AG055422 from the National Institute on Aging (NIA), NIH, Bethesda, MD, USA. TW is supported by grant AG08051 from NIA.
  </p>
 </fn>
 <fn fn-type="COI-statement">
  <p>
   <bold>Competing interests:</bold> AM, QR, KMP, DAD, WCK, EA, HA, JP, MK have no competing interests. DPD is a consultant to Acadia, Eisai, Genentech, Avanir, Neuronix, Grifols and BXcel Therapeutics and has grant support from the National Institute of Aging. EDH is a consultant to Biogen and Ionis. TW is a consultant to Alzemend Neuro, Inc. and Grifols and has grant support from the National Institute of Health and the National Institute on Aging. KLB has grant support from Lilly, Amylx and Biohaven. AAG is contracted with Merck. GHP has grant support from the National Institute on Aging. YS is a consultant to Eli Lilly, Axovant, Takeda, and AbbVie, has donated to Piramal Imaging Limited, has grant support from California Walnut Commission, and has a license for the Dependence Scale.
  </p>
 </fn>
 <fn fn-type="other">
  <p>
   <bold>Patient consent for publication:</bold> Not required.
  </p>
 </fn>
 <fn fn-type="other">
  <p>
   <bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.
  </p>
 </fn>
</fn-group>
